Clinofibrate

This classification denotes an anti-lipidemic agent with the molecular formula C28H36O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0374EZJ8CU, chemically known as 2,2-(cyclohexylidenebis(p-phenyleneoxy))bis(2-methylbutyric acid) but generally known as clinofibrate, which bears US NIH Compound Identifier 2787. European Medicines Agency schedules Clinofibrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06666MIG. The term CLINOFIBRATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, No 10 1978, List 18). CLINOFIBRATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule clinofibrate under HS 29189900 and SITC 51396. As of Q4 2014, CLINOFIBRATE remains the US FDA Preferred Term for this commodity. Clinofibrate bears US NLM identifiers UMLS ID C0055883 and NCI Concept Code C78052. SMILES: O(c1ccc(C2(CCCCC2)c2ccc(OC(CC)(C)C(=O)O)cc2)cc1)C(CC)(C)C(=O)O.